3-Bromo-5-(isopropylthio)-1,2,4-thiadiazole

Catalog No.: 
ACELXJ963
CAS No.: 
36955-40-5
Molecular Formula: 
C5H7BrN2S2
Molecular Weight: 
239.16
3-Bromo-5-(isopropylthio)-1,2,4-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$202.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-(isopropylthio)-1,2,4-thiadiazole
IUPAC Name3-bromo-5-(isopropylthio)-1,2,4-thiadiazole
MDL No.MFCD15072124
Molecular FormulaC5H7BrN2S2
Molecular Weight239.16
SMILESCC(SC1=NC(Br)=NS1)C
InChI KeyOGWQEFUXUMZTJI-UHFFFAOYSA-N
Synonym3-bromo-5-(isopropylthio)-1,2,4-thiadiazole;3-bromo-5-[(1-methylethyl)thio]-1,2,4-Thiadiazole;1,2,4-Thiadiazole, 3-bromo-5-[(1-methylethyl)thio]-
CAS No.36955-40-5

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACELXJ963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYXMV437 route compound structure diagram
    ACYXMV43737159-60-7In Stock
  4. Then
  5. ACELXJ963 route product structure diagram
    ACELXJ96336955-40-5
Inquiry

2. ACELXJ963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELXJ963 route product structure diagram
    ACELXJ96336955-40-5
Inquiry

3. ACELXJ963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELXJ963 route product structure diagram
    ACELXJ96336955-40-5
Inquiry

Comments (0)